Navamedic ASA Financial report for Q1 2012

Navamedic's first quarter 2012 revenues saw a 22 per cent growth over the same period last year. Revenues were NOK 20.6 million compared to NOK 16.8 million in 2011. EBITDA for the first quarter reached NOK 0.1 million, compared to NOK -1.0 million in the same period of 2011. Eight generic products are authorized for marketing  in the last two quarters of 2012.

  Group Group
(in NOK '000) Q1 2012 Q1 2011 FY 2011
Revenues 20.588 16.778 71.299
Gross Profit 8.265 6.672 29.272
Gross margin 40% 40% 41%
EBITDA 58 -982 -2.639
EBIT -1.500 -2.669 -9.359

This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

The full report with tables and the presentation can be downloaded from the following links: